Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others) End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes); and Geography
Publication Month: Aug 2020 | Report Code: TIPMD00002230 | No. of Pages: 169 | Category: Medical Device | Status: Published
The cartilage degeneration market is expected to reach US$ 14,580.10 million in 2027 from US$ 10,459.93 million in 2019. The market is estimated to grow with a CAGR of 4.4% from 2020-2027.
Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.The global cartilage degeneration market is driven by factors such as growing number of sports injuries, and increasing prevalence of obesity. However, the high cost of cartilage repair hampers the market growth. Additionally, growing number of product approvals and developments are creating growth opportunities for the market players.
Lucrative Regional Markets for Cartilage Degeneration
Get more information on this report :
Market Insights
Increasing Prevalence of Obesity
Obesity has a considerable effect on the musculoskeletal system, resulting into degeneration of bones, cartilage, and ligaments. Moreover, the condition, along with other prominent factors, is strongly allied with the increased risk of rapid cartilage loss. The growing prevalence of obesity is likely to accelerate the incidence of cartilage degeneration, which will drive the market growth.
According to the study published by the World Health Organization (WHO) in 2020, the frequency of obesity among the worldwide population has tripled since 1975. Furthermore, according to the same study, 38 million children below 5 years of age were overweight in 2019 worldwide. This massive prevalence of obesity is likely to accelerate due to unhealthy lifestyles such as consumption of junk food, sedentary lifestyle, genetic conditions, and deprivation of mental health. For instance, according to a study published by the Centers of Disease Control and Prevention, the prevalence of obesity grew from 30.5% to 42.4% during past two decades in the US. Overweight conditions among players and athletes can lead to the increasing prevalence of sports injuries. For instance, according to a study published in the British Journal of Sports Medicine in 2015, athletes with BMI index more than 30 kg/m2 are highly susceptible generationto the sports injuries. Such association between obesity and cartilage degeneration is anticipated to drive the market growth by 2027.
Application Insights
Based on application, the cartilage degeneration market is segmented into knee, hip, and other applications. In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to study published on online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed massive growth of around 40.0% during past 4 decades. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.
Global Cartilage degeneration market, by Application– 2018 and 2027
Get more information on this report :
Procedure Type Insights
The cartilage degeneration market, by procedure type, is segmented into osteochondral transplant, chondroplasty, joint replacement, meniscus transplants, cell-based cartilage resurfacing, and other procedure types. The joint replacement segment held the largest share of the market in 2019, whereas the cell-based cartilage resurfacing segment is anticipated to register the highest CAGR in the market during the forecast period.
End User Insights
Based on end user, the cartilage degeneration market is segmented into hospitals and specialty clinics, ambulatory surgical centers and,academic & research institutes. The hospitals and specialty clinicssegment held the largest share of the market in 2019. Also, the segment is estimated to register the highest CAGR in the market during the forecast period.
Strategic Insights
Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfoliostomeet the growing consumer demand. The cartilage degeneration marketplayers adopt the collaborationsstrategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
Global Cartilage degeneration market– ByProcedure type
- Osteochondral Transplant
- Chondroplasty
- Joint Replacement
- Meniscus Transplants
- Cell-based Cartilage Resurfacing
- Others Procedures
Global Cartilage degeneration market– By Application
- Knee
- Hip
- Other Applications
Global Cartilage degeneration market– By End User
- Hospitals and Specialty
- Clinics, Ambulatory Surgical Centres
- Academic and Research Institutes
Cartilage degeneration market– By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Zimmer Biomet
- CartiHeal Inc.
- Vericel Corporation
- Depuy Synthes
- Anika Therapeutics, Inc.
- Conmed Corporation
- Arthrex,Inc.
- B. Braun Melsungen AG
- Stryker
- Smith and Nephew Plc..
Frequently Asked Questions
The List of Companies - Cartilage Degeneration Market
- Zimmer Biomet
- CartiHeal Inc.
- Vericel Corporation
- Depuy Synthes
- Anika Therapeutics, Inc.
- Conmed Corporation
- Arthrex,Inc.
- B. Braun Melsungen AG
- Stryker
- Smith and Nephew Plc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cartilage degenerationmarket.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cartilage degenerationmarket, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000
-
$4550 $3640
-
$6550 $5240
-
$8550 $6840
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount